Developer docs
API playgroundTry for free, no card

Search company profiles

The Valens Company

Full company profile

uuid00058n1

Namestring
The Valens Company
Legal namestring
The Valens Company
Websiteurl
thevalenscompany.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

The Valens Company was a Kelowna, Canada-based licensed cannabis producer operating across cultivation, processing, and manufacturing of regulated cannabis products, with a multi-banner product portfolio assembled primarily through acquisitions (Verse Cannabis, Citizen Stash Cannabis Corp., Green Roads, and LYF Food Technologies). The company served Canadian adult-use consumers through licensed cannabis retail channels, positioning across both premium flower (via Citizen Stash) and value-tier (via Verse) segments, and signaled intent to enter the US market. Revenue mechanics were derived from one-time wholesale and retail sales of cannabis products under Canadian regulatory licensing, supplemented by brand-acquisition-led portfolio expansion. The company secured a CAD$40 million non-revolving term loan in December 2021 to fund growth and balance sheet strengthening, and was subsequently acquired by SNDL Inc., Canada's largest regulated product platform, becoming part of its consolidated cannabis operations.

Short descriptiontext

The Valens Company was a Kelowna, Canada-based licensed cannabis producer building a multi-banner portfolio (Verse, Citizen Stash, Green Roads) for Canadian adult-use retail and future US entry, later acquired by SNDL Inc.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersKelowna, Canada
HQ citystring
Kelowna
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cannabis products, cannabis extraction, cannabinoid manufacturing, cannabis branding, cannabis distribution
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Cannabis Products
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Cannabis Production and Sales
TypeOne Time License
Description

Licensed cannabis producer generating revenue through cultivation, processing, and sale of cannabis products including flower-based products and value brands

prnewswire.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

The Valens Company is a Canadian licensed cannabis producer that cultivates, processes, and manufactures cannabinoid-based consumer products. The company operates a portfolio of branded cannabis products, including the Verse Cannabis and Citizen Stash Cannabis brands, value-priced cannabis offerings, and acquired CBD and edibles brands (Green Roads, LYF Food Technologies), serving both Canadian and select U.S. markets.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The Valens Company is a licensed cannabis producer in Canada operating as a multi-banner platform. The company's product portfolio consists of acquired cannabis brands including Verse Cannabis (completed acquisition) and Citizen Stash Cannabis (acquisition announced/planned), with emphasis on both value brands and premium cannabis flower products. The company focuses on cultivation, processing, and manufacturing of regulated cannabis products for the Canadian market with plans for US market entrance.

Product and service1 record
1Verse Cannabis
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Verse Cannabis
Strategic tierCoreTypeOthersAnnounced on2021-09-01
Description

Completed acquisition of Verse Cannabis, expanding product portfolio, market share, and operational flexibility with emphasis on value brands.

2Citizen Stash Cannabis Corp.
Strategic tierCoreTypeOthersAnnounced on2021-08-31
Description

All-share transaction valued at approximately $54.3 million to expand into flower-based market and enhance product portfolio. Expected to be accretive to financial performance before synergies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Canopy Growth Corporation
TypeDirect peer
Description

One of Canada's largest licensed cannabis producers. Directly comparable to Valens as a multi-category Canadian cannabis producer with significant flower, value-brand, and processed-product exposure.

2Tilray Brands
TypeDirect peer
Description

Major Canadian-anchored cannabis producer with a multi-banner brand strategy similar to Valens' Verse Cannabis and Citizen Stash approach. Comparable across flower, value brands, and extraction-derived products.

3Aurora Cannabis
TypeDirect peer
Description

Large Canadian licensed cannabis producer with significant cultivation and processing capability. A natural direct peer for Valens' producer/manufacturer footprint and Canadian market concentration.

4OrganiGram Holdings
TypeDirect peer
Description

Canadian cannabis producer with a multi-banner strategy spanning value and premium positioning. Highly comparable to Valens' dual premium-value brand structure post-Citizen Stash and Verse Cannabis acquisitions.

5MediPharm Labs
TypeDirect peer
Description

Canadian cannabis extraction specialist focused on producing cannabis derivatives for consumer brands. Closely comparable to Valens' extraction-and-commercialization positioning described in its biotech self-characterization.

6Village Farms International
TypeDirect peer
Description

Canadian-headquartered cannabis producer with cultivation, processing, and brand operations. Comparable producer/manufacturer footprint in the regulated Canadian market with multi-banner exposure.

7Cronos Group
TypeDirect peer
Description

Canadian licensed cannabis producer with multi-product portfolio across flower, derivatives, and value brands. Directly comparable to Valens' diversified product mix and Canadian-only revenue base.

8SNDL Inc.
TypeBroad incumbent
Description

Acquirer of The Valens Company and now its parent; Canada's largest regulated product platform with multi-banner liquor and cannabis retail plus cultivation, processing, and manufacturing. Operates Valens' brands as part of a broader portfolio.

9Green Thumb Industries
TypeBroad incumbent
Description

US multi-state cannabis operator with cultivation, processing, and retail. Comparable cannabis-product-platform scale to SNDL (Valens' parent), though primarily US-focused and serves as a forward-looking comparable for Valens' US ambitions.

10Trulieve Cannabis Corp.
TypeBroad incumbent
Description

US-anchored multi-state cannabis operator with integrated cultivation, processing, and retail. Comparable as a broad-incumbent producer/retail platform of similar scale to SNDL's cannabis arm, despite a different geographic mix.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Valens Company

Cannabis Productsthevalenscompany.com

The Valens Company was a Kelowna, Canada-based licensed cannabis producer building a multi-banner portfolio (Verse, Citizen Stash, Green Roads) for Canadian adult-use retail and future US entry, later acquired by SNDL Inc.

What The Valens Company does

The Valens Company was a Kelowna, Canada-based licensed cannabis producer operating across cultivation, processing, and manufacturing of regulated cannabis products, with a multi-banner product portfolio assembled primarily through acquisitions (Verse Cannabis, Citizen Stash Cannabis Corp., Green Roads, and LYF Food Technologies). The company served Canadian adult-use consumers through licensed cannabis retail channels, positioning across both premium flower (via Citizen Stash) and value-tier (via Verse) segments, and signaled intent to enter the US market. Revenue mechanics were derived from one-time wholesale and retail sales of cannabis products under Canadian regulatory licensing, supplemented by brand-acquisition-led portfolio expansion. The company secured a CAD$40 million non-revolving term loan in December 2021 to fund growth and balance sheet strengthening, and was subsequently acquired by SNDL Inc., Canada's largest regulated product platform, becoming part of its consolidated cannabis operations.

The Valens Company firmographics

Firmographics
Name
The Valens Company
Legal name
The Valens Company
Website
https://thevalenscompany.com
Company type
Private
Founded year
2014
Operating status
Acquired
Headcount range
51–100 employees
Short description
The Valens Company was a Kelowna, Canada-based licensed cannabis producer building a multi-banner portfolio (Verse, Citizen Stash, Green Roads) for Canadian adult-use retail and future US entry, later acquired by SNDL Inc.
Ownership category
akta.pro rank

Where The Valens Company is headquartered

Location

Headquarters

HQ city
Kelowna
HQ country
Canada
HQ region
North America

Markets served

The Valens Company business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Cannabis Production and Sales: Licensed cannabis producer generating revenue through cultivation, processing, and sale of cannabis products including flower-based products and value brands

Go-to-market motion2 records

Distribution channels1 record

The Valens Company product offering

Product offering

Core offering

The Valens Company is a Canadian licensed cannabis producer that cultivates, processes, and manufactures cannabinoid-based consumer products. The company operates a portfolio of branded cannabis products, including the Verse Cannabis and Citizen Stash Cannabis brands, value-priced cannabis offerings, and acquired CBD and edibles brands (Green Roads, LYF Food Technologies), serving both Canadian and select U.S. markets.

Product overview

The Valens Company is a licensed cannabis producer in Canada operating as a multi-banner platform. The company's product portfolio consists of acquired cannabis brands including Verse Cannabis (completed acquisition) and Citizen Stash Cannabis (acquisition announced/planned), with emphasis on both value brands and premium cannabis flower products. The company focuses on cultivation, processing, and manufacturing of regulated cannabis products for the Canadian market with plans for US market entrance.

Differentiator

Problem solved

Functional benefit

Products and services

  • Verse Cannabis

Companies that use The Valens Company

Customer profile

Segments1 record

Ideal customer profiles1 record

The Valens Company technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Valens Company partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Verse CannabiscoreOthers · 1 September 2021Completed acquisition of Verse Cannabis, expanding product portfolio, market share, and operational flexibility with emphasis on value brands.
  • Citizen Stash Cannabis Corp.coreOthers · 31 August 2021All-share transaction valued at approximately $54.3 million to expand into flower-based market and enhance product portfolio. Expected to be accretive to financial performance before synergies.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

The Valens Company competitors and assessment

Company assessment

Direct peers

  • Canopy Growth Corporation: One of Canada's largest licensed cannabis producers. Directly comparable to Valens as a multi-category Canadian cannabis producer with significant flower, value-brand, and processed-product exposure.
  • Tilray Brands: Major Canadian-anchored cannabis producer with a multi-banner brand strategy similar to Valens' Verse Cannabis and Citizen Stash approach. Comparable across flower, value brands, and extraction-derived products.
  • Aurora Cannabis: Large Canadian licensed cannabis producer with significant cultivation and processing capability. A natural direct peer for Valens' producer/manufacturer footprint and Canadian market concentration.
  • OrganiGram Holdings: Canadian cannabis producer with a multi-banner strategy spanning value and premium positioning. Highly comparable to Valens' dual premium-value brand structure post-Citizen Stash and Verse Cannabis acquisitions.
  • MediPharm Labs: Canadian cannabis extraction specialist focused on producing cannabis derivatives for consumer brands. Closely comparable to Valens' extraction-and-commercialization positioning described in its biotech self-characterization.
  • Village Farms International: Canadian-headquartered cannabis producer with cultivation, processing, and brand operations. Comparable producer/manufacturer footprint in the regulated Canadian market with multi-banner exposure.
  • Cronos Group: Canadian licensed cannabis producer with multi-product portfolio across flower, derivatives, and value brands. Directly comparable to Valens' diversified product mix and Canadian-only revenue base.

Broad incumbents

  • SNDL Inc. Acquirer of The Valens Company and now its parent; Canada's largest regulated product platform with multi-banner liquor and cannabis retail plus cultivation, processing, and manufacturing. Operates Valens' brands as part of a broader portfolio.
  • Green Thumb Industries: US multi-state cannabis operator with cultivation, processing, and retail. Comparable cannabis-product-platform scale to SNDL (Valens' parent), though primarily US-focused and serves as a forward-looking comparable for Valens' US ambitions.
  • Trulieve Cannabis Corp. US-anchored multi-state cannabis operator with integrated cultivation, processing, and retail. Comparable as a broad-incumbent producer/retail platform of similar scale to SNDL's cannabis arm, despite a different geographic mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

The Valens Company social profiles

Digital presence

The Valens Company financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Valens Company leadership team

Management profile

Number of profiles

Profiles5 records

The Valens Company subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

The Valens Company funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Valens Company M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Valens Company

What does The Valens Company do?

The Valens Company is a Canadian licensed cannabis producer that cultivates, processes, and manufactures cannabinoid-based consumer products. The company operates a portfolio of branded cannabis products, including the Verse Cannabis and Citizen Stash Cannabis brands, value-priced cannabis offerings, and acquired CBD and edibles brands (Green Roads, LYF Food Technologies), serving both Canadian and select U.S. markets.

Is The Valens Company a public or private company?

The Valens Company is a private company. It is classified as corporate owned and is currently acquired.

When was The Valens Company founded?

The Valens Company was founded in 2014. It employs 51 to 100 people.

Where is The Valens Company based?

The Valens Company is headquartered in Kelowna, Canada, in the North America region.

How does The Valens Company make money?

One revenue line is on record: cannabis Production and Sales.

Who are The Valens Company's main competitors?

Direct peers on record are Canopy Growth Corporation, Tilray Brands, Aurora Cannabis, OrganiGram Holdings, MediPharm Labs, Village Farms International and Cronos Group. Broad incumbents are SNDL Inc., Green Thumb Industries and Trulieve Cannabis Corp..

Does The Valens Company have an API?

No public API is recorded for The Valens Company.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireSNDL Completes Acquisition of The Valens CompanySNDL Inc. has completed the acquisition of The Valens Company Inc. for approximately $138 million, combining their operations to create a vertically integrated Canadian cannabis entity with over $1 billion in annualized pro forma revenue. The transaction is expected to increase SNDL's overall cannabis market share from 1.0% to 3.8% and deliver more than $10 million in annual cost synergies through operational rationalization.PR NewswireTHE VALENS COMPANY OBTAINS FINAL COURT ORDER APPROVING THE PROPOSED PLAN OF ARRANGEMENT WITH SNDLThe Ontario Superior Court of Justice granted final approval for The Valens Company's proposed plan of arrangement with SNDL Inc. Under the deal, Valens shareholders will receive 0.3334 of a SNDL share per Valens share, representing an implied value of $1.26 per share and total consideration of approximately $138 million. The transaction remains subject to customary closing conditions and is expected to close during January 2023.PR NewswireThe Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price RuleThe Valens Company Inc. has received a 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, with the new deadline set for June 12, 2023, following the expiration of the initial compliance period on December 12, 2022. The company intends to cure the deficiency by effecting a share consolidation if necessary and has confirmed it will appeal any subsequent delisting determination to a Nasdaq Hearings Panel. The announcement also notes the company expects to close its pending acquisition by SNDL Inc. in January 2023, where SNDL will acquire all outstanding Valens common shares at a ratio of 0.3334 SNDL shares per Valens share.PR NewswireBOTH LEADING INDEPENDENT PROXY ADVISORS RECOMMEND SHAREHOLDERS OF THE VALENS COMPANY INC. VOTE FOR THE PROPOSED ARRANGEMENT WITH SNDL INC.Proxy advisory firms ISS and Glass Lewis have recommended that shareholders of The Valens Company Inc. vote in favor of a proposed acquisition arrangement with SNDL Inc. The transaction involves SNDL acquiring all outstanding shares of Valens in exchange for SNDL stock, aiming to create a combined entity expected to generate over $15 million in annual EBITDA through synergies. This merger is intended to position the new company as a top-10 licensed cannabis producer in Canada with enhanced market liquidity and cost efficiencies.PR NewswireValens Secures Sales Licence for Greater Toronto Area Beverage FacilityThe Valens Company Inc. received a sales licence amendment from Health Canada for its Pommies manufacturing facility in the Greater Toronto Area, enabling direct sales of micro processed cannabis products to provincial distributors. Previously, Valens relied on its British Columbia sales licence to access provincial distributors, which added cost and complexity to its supply chain. The company expects the amendment to streamline distribution, improve margins, and support further product launches, with its cannabis beverage market share in Alberta, British Columbia, Ontario, and Saskatchewan growing from 5.5% in Q1 2021 to 9.0% in Q3 2022.PR NewswireTHE VALENS COMPANY ANNOUNCES MAILING AND FILING OF CIRCULAR FOR SPECIAL MEETING OF SHAREHOLDERS TO APPROVE ARRANGEMENT WITH SNDL INC.The Valens Company Inc. announced the mailing of its management information circular for a Special Meeting of Shareholders on November 29, 2022, to vote on a plan of arrangement under which SNDL Inc. will acquire all outstanding common shares of Valens. Valens shareholders will receive 0.3334 SNDL shares per Valens share, representing an implied value of $1.26 per share and a 48% premium based on the 10-day volume-weighted average price prior to the non-binding expression of interest. The Valens Board unanimously approved the arrangement and recommends shareholders vote in favor, with the transaction expected to deliver over $10 million in annual cost synergies and approximately $15 million in additional EBITDA through combined operations.PR NewswireThe Valens Company Reports Third Quarter Fiscal 2022 Financial ResultsThe Valens Company reported Q3 fiscal 2022 results showing improved operational efficiency with cash flow from operations improving by $12.2 million and adjusted gross margin expanding to 24.9% from 17.2% in Q2 2022, though net revenue declined 15.4% to $20.3 million. The company also announced entering into an arrangement agreement to be acquired by SNDL, which would create a leading vertically integrated cannabis entity in Canada with projected annual cost synergies exceeding $10 million and approximately $15 million of additional EBITDA on an annual run-rate basis.PR NewswireThe Valens Company to Release Financial Results for the Third Quarter of 2022The Valens Company announced that it will release its financial results for the third quarter of 2022 on October 13, 2022. The company also highlighted a proposed plan of arrangement transaction with SNDL Inc., noting that the completion of this deal is subject to meeting specific Nasdaq listing standards.PR NewswireSNDL Announces Agreement to Acquire The Valens Company to Create Leading Vertically Integrated Cannabis PlatformSNDL Inc. has entered into an agreement to acquire The Valens Company in an all-stock transaction valued at approximately $138 million, creating a leading vertically integrated cannabis platform in Canada. The combined entity will operate under the SNDL name and is expected to generate over $10 million in annual cost synergies while holding approximately $314 million in net cash. The transaction requires shareholder and regulatory approvals with a closing expected in January 2023.PR NewswireThe Valens Company Announces Nomination of Independent Director to Board of DirectorsThe Valens Company Inc. announced the nomination of Ms. Aïda Moudachirou-Rébois, Senior Vice President and Global Chief Marketing Officer at MAC Cosmetics, to its Board of Directors at the Annual General Meeting on August 2, 2022. If elected, she would become the sixth independent director on the seven-member board, bringing global consumer packaged goods brand-building expertise. The nomination is part of Valens' ongoing efforts to strengthen corporate governance, following recent changes including separating the Chair and CEO roles.